Manufacturing CNS Medication
There are many different types of drugs that work on the central nervous system (CNS), including anesthetics, anticonvulsants, antiemetics, anti-Parkinson agents, stimulants, muscle relaxants and sedatives.
As many of these products can cause serious side-effects from occupational exposure, containment is a key aspect to consider during the manufacturing process. As containment experts, we not only offer the largest variety of solutions for contained processing, but also unrivaled experience in identifying the most appropriate solution based on a containment risk analysis.
Delivering medication to the central nervous system remains challenging, which is why the industry continues to look at alternative methods of administration, such as the intranasal route or the use of colloidal drug carriers.
For inhalable versions, homogeneity and stability are key factors. Our dry powder blending, spray drying and particle engineering capabilities ensure that the production of free-flowing, aerodynamic particles at the correct size is achievable at the scale you need.
We also supply proven solutions for solid dispersions for bioavailability enhancement, such as extrusion, spheronization and a complete engineering service from system design to process integration and optimization.
Furthermore, we understand that during early research and development (R&D), the availability of the active ingredient is often limited. As such, there is an absolute requirement for process equipment that is capable of producing just a few hundred grams of finished product to fast-track new drug formulations.
Designed for small-scale and R&D applications, particularly with potent actives, the PharmaConnect®-PLUS — based on the established combination of a single control unit with a diverse range of process modules — is GEA’s modular granulation, extrusion/spheronization and blending system that offers an unbeatable range of process types and capacities, and also integrates with the Flexstream range of fluidized bed processors.
In addition, the ConsiGma® 4.0 platform combines Quality by Design (QbD) principles with DoE to explore and optimize a wide range of process parameters with less product in a shorter time frame.
Productos y tecnologías
Mostrar 4 de 26
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Continuous Processing Lines for Pharma
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Downloads
GEA Insights
El avance que revolucionó el secado por atomización
En 1976, los ingenieros de NIRO respondieron a un reto competitivo replanteándose las posibilidades del secado por atomización. Su idea se materializó en la torre multietapa MSD. Cincuenta años después, ese mismo principio fundamental contribuye a transformar los líquidos en los productos en polvo que se utilizan en productos nutricionales esenciales y en medicamentos importantes en todo el mundo. Perfeccionada a lo largo de décadas de experiencia en ingeniería, conocimiento de las necesidades de los clientes y desarrollo continuo, la torre de atomización MSD es una historia de innovación con un impacto duradero.
Más allá de la máquina: cómo potenciar el rendimiento de la planta
El hecho de que una máquina sea eficiente no significa que la fábrica lo sea. La mejora real suele comenzar por ir más allá de los equipos individuales y comprender cómo los procesos, los sistemas energéticos y las decisiones operativas se influyen mutuamente. Se trata de un enfoque holístico diseñado para descubrir oportunidades que, de otro modo, podrían pasarse por alto.
Cómo una válvula transforma la manera de elaborar alimentos y bebidas
En las plantas de alimentación y bebidas, las válvulas suelen accionarse mediante aire comprimido. GEA Hydract® Actuation Technology mueve las válvulas mediante agua, en un circuito cerrado controlado digitalmente. El resultado es una válvula que puede mantenerse en su sitio con exactitud y regularse con precisión. Esto se traduce en un menor consumo energético y un mayor control.
